GRAIL stock jumps as Galleri outlook and FDA filing timeline come back into focus Shares of GRAIL surged 13.2% to $114.41 Thursday afternoon, topping out at an intraday high of $118.50 earlier in the session. 22 January 2026 Biotechnology·NASDAQ:GRAL.O
